Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
Author(s) -
Barry A. Borlaug,
Kevin J. Anstrom,
Gregory D. Lewis,
Sanjiv J. Shah,
James A. Levine,
Gabe A. Koepp,
Michael M. Givertz,
G. Michael Felker,
Martin M. LeWinter,
Douglas L. Mann,
Kenneth B. Margulies,
Andrew L. Smith,
W.H. Wilson Tang,
David J. Whellan,
Horng H. Chen,
Víctor G. DávilaRomán,
Steven E. McNulty,
Patrice DesvigneNickens,
Adrian F. Hernandez,
Eugene Braunwald,
Margaret M. Redfield
Publication year - 2018
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2018.14852
Subject(s) - medicine , placebo , tolerability , ejection fraction , heart failure , nitrite , crossover study , vo2 max , adverse effect , cardiology , clinical endpoint , brain natriuretic peptide , heart rate , randomized controlled trial , blood pressure , nitrate , alternative medicine , pathology , ecology , biology
There are few effective treatments for heart failure with preserved ejection fraction (HFpEF). Short-term administration of inorganic nitrite or nitrate preparations has been shown to enhance nitric oxide signaling, which may improve aerobic capacity in HFpEF.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom